...
首页> 外文期刊>MBio >Correction for Olsen et al., “Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication”
【24h】

Correction for Olsen et al., “Polyamines and Hypusination Are Required for Ebolavirus Gene Expression and Replication”

机译:对Olsen等人的修正,“多巴胺和hypusination是埃博拉病毒基因表达和复制所必需的”

获取原文
   

获取外文期刊封面封底 >>

       

摘要

AUTHOR CORRECTION Volume 7, no. 4, e00882-16, 2016, https://doi.org/10.1128/mBio.00882-16 . We correct the following error in our published paper. In Materials and Methods, we described all support plasmids used in the ebolavirus (EBOV) minigenome studies as having a pTM1 backbone. Resequencing of our stocks showed that one plasmid, the VP30 plasmid used in all transfections, was a pCaggs expression vector, not a pTM1 vector. All other plasmids were verified to be pTM1 based by restriction digestion and sequencing. This led us to examine whether exchanging the pTM1-expressed VP30 for the pCaggs-expressed VP30 had any effect on our reported findings. Our findings are that VP30 mRNA expressed from the pCaggs vector accumulates and that hypusinated eIF5A is required for protein accumulation. When a pTM1-based VP30 expression vector is used, VP30 protein accumulates to the same or higher levels in the absence of hypusinated eIF5A ( Fig.?1 ). This is the opposite phenotype observed with the pCaggs expression vector. Our results suggest that there are vector-specific sequences in pCaggs that decrease VP30 protein accumulation following the inhibition of hypusination and that the inherent coding sequence of VP30 is not the source of eIF5A dependence. FIG?1? VP30 protein expressed from a pTM1 expression vector accumulates to significantly higher levels when hypusination is inhibited by GC7 treatment. (Left) Representative Western blot of VP30 protein levels and an Hsp90 loading control with and without GC7 treatment; (right) quantification of VP30 protein levels from 4 independent experiments. Error bars represent standard errors of the means. Ratio paired t ?test, P = 0.0143. These results do not alter the main conclusions of our paper, namely, that blockade of polyamines or blockade of eIF5A hypusination results in a decrease in EBOV replication. These results alter our proposed mechanism by which the hypusination blockade alters EBOV replication and show that low levels of VP30 protein are not the only restriction to EBOV replication (though they likely contribute to this phenotype under the conditions that we tested). Future studies will investigate this phenomenon both in pCaggs expression vectors and in EBOV infection. Please also note that the affiliation line should appear as shown above.
机译:作者更正第7卷,第。 4,e00882-16,2016,https://doi.org/10.1128/mBio.00882-16。我们在已发表的论文中纠正了以下错误。在材料和方法中,我们将埃博拉病毒(EBOV)微型基因组研究中使用的所有支持质粒描述为具有pTM1主链。对我们的原种重新测序表明,一种质粒,即所有转染中使用的VP30质粒,是pCaggs表达载体,而不是pTM1载体。通过限制性酶切和测序证实所有其他质粒均为pTM1。这促使我们检查将pTM1表达的VP30替换为pCaggs表达的VP30是否对我们报告的发现有任何影响。我们的发现是从pCaggs载体表达的VP30 mRNA会积累,而蛋白积累则需要经过水处理的eIF5A。当使用基于pTM1的VP30表达载体时,VP30蛋白在不存在被hypusinized eIF5A的情况下积累至相同或更高的水平(图?1)。这是使用pCaggs表达载体观察到的相反表型。我们的结果表明,pCaggs中存在载体特异性序列,这些序列会在抑制hypusination后降低VP30蛋白的积累,而VP30的固有编码序列并非eIF5A依赖性的来源。图。1?当GC7处理抑制了hypusification时,从pTM1表达载体表达的VP30蛋白积累到明显更高的水平。 (左)在有或没有GC7处理的情况下,VP30蛋白水平和Hsp90上样对照的代表性蛋白质印迹; (右)来自4个独立实验的VP30蛋白水平的量化。误差棒代表均值的标准误差。比率成对t检验,P = 0.0143。这些结果没有改变我们论文的主要结论,即,多胺的阻断或eIF5A羟化作用的阻断导致EBOV复制的减少。这些结果改变了我们提出的机制,通过hypusination阻断改变了EBOV复制,并表明低水平的VP30蛋白并不是EBOV复制的唯一限制(尽管在我们测试的条件下它们很可能对该表型有所贡献)。未来的研究将在pCaggs表达载体和EBOV感染中研究这种现象。另请注意,联盟行应如上所示。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号